Journal article 868 views 249 downloads
Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study
Steve Bain 
,
Bendix Carstensen,
Liselotte Hyveled,
Stephanie Seremetis,
Frederik Flindt Kreiner ,
Hanan Amadid,
Alice Clark
,
Bendix Carstensen,
Liselotte Hyveled,
Stephanie Seremetis,
Frederik Flindt Kreiner ,
Hanan Amadid,
Alice Clark
BMJ Open Diabetes Research & Care, Volume: 11, Issue: 3, Start page: e003300
Swansea University Author:
Steve Bain
-
PDF | Version of Record
© Author(s), 2023. Re-use permitted under CC BY-NC. No commercial re-use.
Download (1.1MB)
DOI (Published version): 10.1136/bmjdrc-2022-003300
Abstract
Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study
| Published in: | BMJ Open Diabetes Research & Care |
|---|---|
| ISSN: | 2052-4897 |
| Published: |
BMJ
2023
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa63949 |
| Item Description: |
Letter |
|---|---|
| College: |
Faculty of Medicine, Health and Life Sciences |
| Funders: |
Novo Nordisk A/S. |
| Issue: |
3 |
| Start Page: |
e003300 |